Found: 24
Select item for more details and to access through your institution.
Editorial: hepatitis B, fatty liver and metabolic syndrome—Interaction or co‐existence? Authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Letter: effect of HCV eradication on cardiovascular disease—Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1169, doi. 10.1111/apt.15017
- By:
- Publication type:
- Article
The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1099, doi. 10.1111/apt.15010
- By:
- Publication type:
- Article
Letter: gluten sensitivity in patients with inflammatory bowel disease.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Randomised clinical trial: reducing the intake of dietary FODMAPs of breastfeeding mothers is associated with a greater improvement of the symptoms of infantile colic than for a typical diet.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1061, doi. 10.1111/apt.15007
- By:
- Publication type:
- Article
Letter: association between proton pump inhibitors and the risk of hepatocellular carcinoma—authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti‐viral therapy in patients with chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1128, doi. 10.1111/apt.15006
- By:
- Publication type:
- Article
Editorial: which inflammatory bowel disease patients should be screened for Epstein‐Barr virus infection? Authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1082, doi. 10.1111/apt.15000
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1044, doi. 10.1111/apt.15001
- By:
- Publication type:
- Article
Letter: effects of HCV eradication on cardiovascular diseases.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Clinical relevance of serum non‐organ‐specific antibodies in patients with HCV infection receiving direct‐acting antiviral therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1138, doi. 10.1111/apt.14999
- By:
- Publication type:
- Article
Editorial: predicting recurrence of Crohn's disease after surgical resection—Close to a crystal ball. Authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Microbial translocation and T cell activation are modified by direct‐acting antiviral therapy in HCV‐infected patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1146, doi. 10.1111/apt.14994
- By:
- Publication type:
- Article
Editorial: hepatitis B, fatty liver, and metabolic syndrome—interaction or co‐existence?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Anxiety after coeliac disease diagnosis predicts mucosal healing: a population‐based study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1091, doi. 10.1111/apt.14991
- By:
- Publication type:
- Article
Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1117, doi. 10.1111/apt.14990
- By:
- Publication type:
- Article
Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non‐erosive reflux disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1074, doi. 10.1111/apt.14986
- By:
- Publication type:
- Article
Predictors of advanced fibrosis in non‐cirrhotic non‐alcoholic fatty liver disease in Germany.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1109, doi. 10.1111/apt.14976
- By:
- Publication type:
- Article
Letter: faecal calprotectin, clinical indices and the diagnosis of inflammatory bowel disease.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Editorial: predicting recurrence of Crohn's disease after surgical resection—close to a crystal ball.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Editorial: which inflammatory bowel disease patients should be screened for Epstein‐Barr virus infection?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Letter: proton pump inhibitors and the risk of hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1041, doi. 10.1111/apt.14316
- Publication type:
- Article